Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

Abstract Introduction Continuous measures of amyloid burden as measured by positron emission tomography (PET) are being used increasingly to stage Alzheimer's disease (AD). This study examined whether cerebrospinal fluid (CSF) and plasma amyloid beta (Aβ)42/Aβ40 could predict continuous values...

Descrición completa

Detalles Bibliográficos
Main Authors: Julie K. Wisch, Brian A. Gordon, Anna H. Boerwinkle, Patrick H. Luckett, James G. Bollinger, Vitaliy Ovod, Yan Li, Rachel L. Henson, Tim West, Mathew R. Meyer, Kristopher M. Kirmess, Tammie L.S. Benzinger, Anne M. Fagan, John C. Morris, Randall J. Bateman, Beau M. Ances, Suzanne E. Schindler
Formato: Artigo
Idioma:English
Publicado: Wiley 2023-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
biomarker concordance
CSF Aβ42/Aβ40
machine learning
PET
plasma Aβ42/Aβ40
Acceso en liña:https://doi.org/10.1002/dad2.12405

Internet

https://doi.org/10.1002/dad2.12405

Títulos similares